Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients: A Retrospective Cohort Study Based on Large-scale Population and Mendelian Randomization Analysis

NCT06531629 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06531629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients: A Retrospective Cohort Study Based on Large-scale Population and Mendelian Randomization Analysis
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2000
Completion date
December 31, 2020
Enrollment
72,408 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer